Skip to main content
. 2020 Aug 23;191:110119. doi: 10.1016/j.envres.2020.110119

Fig. 2.

Fig. 2

a and b: Schematic of the Internalization of nanodrugs through the plasma membrane and targeted drug release (a) and transcytosis of nanodrugs through cell barriers (b). Nanoparticulate drug carriers through the cellular and mechanistic establishment crossed the membranes (blood-brain barrier and blood-testis barrier) and with the help of capping agents such as sulfate polysaccharides/polymers undergo multivalent bond interactions with virus glycoproteins (i.e hemagglutinin (HA).